Daan Gene disclosed its semi-annual performance report on 28 July. In the first half of the year, the company achieved a total operating income of 6.676 billion CNY, a year-on-year increase of 91.68%; net profit attributable to the parent was 3.557 billion CNY, a year-on-year increase of 122.59%; basic earnings per share was 2.5343 CNY.
During the reporting period, the market continued to demand COVID-19 nucleic acid detection kits, nucleic acid detection instruments, and related consumables, which had a positive impact on the company's performance.
Copyright © 2025 GL events Ruihe (Shanghai) Exhibition Co., Ltd. All Rights Reserved. ( 沪ICP备12004745号-1 )
We deliver the latest IVD news straight to your inbox. Stay in touch with CACLP News.
sign-up for our newsletter today.
To ensure our newsletter hit your inbox, make sure to add @caclp.com to your safe senders list. And, as always, feel free to contact
us with any questions and thanks again for subscribing.
Go back
